Oxford, United Kingdom
OrganOx is a UK-based health care startup with a mission to revolutionize organ transplantation and save lives. Founded in 2008 as a spin-out from the University of Oxford, the company is focused on transforming transplantation with its flagship product, the OrganOx metra®. This transportable, automated ex vivo liver perfusion device aims to make every donated organ count.
The core technology behind the OrganOx metra® has been in development for over 15 years, driven by the founders, Professor Peter Friend and Professor Constantin Coussios, both renowned for their work in organ preservation and maintenance. The company's innovative approach aims to replace conventional cold preservation methods with warm preservation, creating an environment that mimics the human body and enables extended preservation times and objective assessment of organ performance.
The latest funding milestone for OrganOx is the £25.00M Venture Round investment led by Lauxera Capital Partners on 17 July 2023. This injection of capital underscores the growing interest in the potential of OrganOx's technology to significantly impact the field of organ transplantation.
As the company continues to gain traction in the health care industry, its innovative approach and strong financial backing position OrganOx as a key player in the effort to address the critical organ shortage and improve transplant outcomes.
